Search results
...STARGLO Study Demonstrates Columvi Significantly Extends Survival in People With Relapsed or...
Morningstar· 2 days agoGenentech’s Phase III STARGLO Study Demonstrates Columvi Significantly Extends Survival in People With Relapsed or Refractory Diffuse Large B-cell Lymphoma ...
FDA approves Amgen’s BLINCYTO for acute lymphoblastic leukaemia
Pharmaceutical Technology via Yahoo Finance· 17 hours agoThe US Food and Drug Administration (FDA) has approved Amgen’s BLINCYTO (blinatumomab) for...
Why Is Penny Stock Mustang Bio Trading Over 190% On Monday? - Mustang Bio (NASDAQ:MBIO)
Benzinga· 12 hours agoMB-106 is being developed in a collaboration between Mustang and Fred Hutch Cancer Center to treat...
Roche (RHHBY) Reports Upbeat Data on Columvi From STARGLO Study
Zacks via Yahoo Finance· 11 hours agoRoche's (RHHBY) Columvi significantly extends survival in patients with relapsed or refractory...
Fate Therapeutics stock upgraded by Piper Sandler on autoimmune focus By Investing.com
Investing.com· 17 hours agoFate Therapeutics is also advancing its Phase I study of ADR-armed FT522 (CD19 CAR-INK) for patients...
Nurix Therapeutics, With 345% Run, Posts A 'Clear Win' In Leukemia Treatment
Investor's Business Daily· 5 hours agoNurix's approach degrades a protein called BTK. Doing so blocks defective B cells, which can drive...
Pfizer reports data from Phase II multiple myeloma treatment trial
Clinical Trials Arena via Yahoo Finance· 17 hours agoPfizer has announced findings from the Phase II MagnetisMM-3 clinical trial of ELREXFIO...
...BLINATUMOMAB) IN CD19-POSITIVE PHILADELPHIA CHROMOSOME-NEGATIVE B-CELL PRECURSOR ACUTE...
Morningstar· 3 days agoFood and Drug Administration (FDA) has approved BLINCYTO® (blinatumomab) for the treatment of adult and pediatric patients one month or older with CD19-positive Philadelphia chromosome-negative ...
Secret Pentagon Anti-Vax Campaign; FDA's Tylenol Warning; E. Coli at the Olympics
MedPage Today· 20 hours agoThe U.S. military waged a secret campaign in the Philippines during the pandemic to cast doubt on...
Roche’s Columvi offers extended survival in Phase III DLBCL trial
Clinical Trials Arena via Yahoo Finance· 17 hours agoRoche has reported findings from the Phase III STARGLO clinical trial where Columvi, in combination...